Create Account | Forget Password?               
Home Asthma Cancer Cardiology Diabetes Neurology Nutrition Pediatrics OB / GYN General
Health Center
Ads & Resources
Comprehensive Health Directory
Manage Patient Records
 
Home » Asthma
 Asthma Videos  « Go Back

HFA Transition Provides an Opportunity to Improve Aerobid® Inhaler : Trudell ramps up production of AEROCOUNT® Dose Indicator in preparation to supply Forest Laboratories, Inc. with commercial volumes to support their CFC to HFA transition on Flunisoli

Posted By: Anonymous | Posted On: Sep 22,2008 18:30 pm | View: 66
Trudell Medical International is pleased to announce the selection of the AEROCOUNT® Dose Indicator for use with Forest’s proprietary product containing the active ingredient Flunisolide in an HFA formulation. Read More: http://www.prweb.com/releases/trudell_medical/medical_international/prweb1374124.htm



 
Other Health Sources
About Us |  Contact Us |  Asthma |  Cancer |  Cardiology |  Diabetes |  Neurology |  Diet & Nutrition |  Pediatrics |  OB/GYN |  General
Copyright © 2008-2012, DoctorsOutlook.com, All Rights Reserved.
Disclaimer: Issuers of the submissions/postings are solely responsible for the content of their submissions. Doctorsoutlook.com can't be held liable for the contents of these submissions. In case any submission damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.